Written by Stuart Stevens | Thursday, 05 July 2007
The Food & Drug Administration of America has given the full approval for lower dose versions of the influenza drug Tamiflu. Normally Tamiflu comes in 75 mg capsules but following the green light from the FDA it will now be available in smaller quantities of 30 mg and 45 mg. The idea is that this will make it easier for very young children and infants to be given the drug. The standard 75 mg capsules will still be made available for sale too.

The Tamiflu drug that is made by the drug company Roche is known to be an extremely effective treatment for all varieties of the influenza virus. Recently the Tamiflu drug has become extremely famous as it is recommended by the World Health Organisation to be given to humans who contract the deadly H5N1 bird flu virus. Men and women who are given Tamiflu early on when they contract the bird flu virus have a far greater chance of surviving the virus than men and women who are not given it and rely on other influenza drugs. It is extremely important that Tamiflu is administered in the first 48 hour period (ideally the first 24 hour period) of any influenza symptoms being noted.
Because of the World Health Organisation approval of Tamiflu, health authorities and governments all around the globe have been busy trying to get their paws on as much of it as possible. The drug company Roche has made millions of pounds as a result of this and it is reckoned that the vast majority of the stocks will go unused unless a worldwide pandemic of the H5N1 virus breaks out.
Many individuals also choose to stock up with the Tamiflu drug for their friends and families as an extra precaution should they not be able to get their hands on some of it in the panic of a bird flu pandemic.
